James F. Polewaczyk
Net Worth

Last updated:

What is James F. Polewaczyk net worth?

The estimated net worth of Mr. James F. Polewaczyk is at least $64,064,203 as of 6 Mar 2024. He owns shares worth $6,820,229 as insider, has earned $38,373,974 from insider trading and has received compensation worth at least $18,870,000 in IDEXX Laboratories, Inc..

What is the salary of James F. Polewaczyk?

Mr. James F. Polewaczyk salary is $1,110,000 per year as Executive Vice President & Chief Commercial Officer in IDEXX Laboratories, Inc..

How old is James F. Polewaczyk?

Mr. James F. Polewaczyk is 61 years old, born in 1964.

What stocks does James F. Polewaczyk currently own?

As insider, Mr. James F. Polewaczyk owns shares in one company:

Company Title Shares Price per share Total value
IDEXX Laboratories, Inc. (IDXX) Executive Vice President & Chief Commercial Officer 10,711 $636.75 $6,820,229

What does IDEXX Laboratories, Inc. do?

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDXX logo
IDXX
IDEXX Laboratories, Inc.
$636.75

James F. Polewaczyk insider trading

IDEXX Laboratories, Inc.

Mr. James F. Polewaczyk has made 19 insider trades between 2008-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 18,868 units of IDXX stock on 17 Feb 2011. As of 6 Mar 2024 he still owns at least 10,711 units of IDXX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 755 $206.94 $156,240
Option
Non-Qualified Stock Option (right-to-buy) 2,981 $247.86 $738,871
Option
Non-Qualified Stock Option (right-to-buy) 4,640 $544.08 $2,524,531
Sale
Common Stock 4,134 $557.94 $2,306,528
Sale
Common Stock 3,290 $558.88 $1,838,722
Sale
Common Stock 680 $559.33 $380,346
Option
Incentive Stock Option (right-to-buy) 483 $206.94 $99,952
Option
Common Stock 4,640 $544.08 $2,524,531
Option
Common Stock 2,226 $288.78 $642,824
Option
Common Stock 483 $206.94 $99,952
Option
Restricted Stock Unit 161 N/A N/A
Option
Common Stock 126 N/A N/A
Option
Restricted Stock Unit 204 N/A N/A
Option
Common Stock 216 N/A N/A
Option
Common Stock 161 N/A N/A
Option
Restricted Stock Unit 220 N/A N/A
Option
Common Stock 204 N/A N/A
Option
Common Stock 220 N/A N/A
Sale
Common Stock 3,940 $523.56 $2,062,811
Option
Non-Qualified Stock Option (right-to-buy) 4,956 $206.94 $1,025,595
Option
Common Stock 6,680 $288.78 $1,929,050
Sale
Common Stock 3,116 $520.19 $1,620,918
Sale
Common Stock 3,378 $521.01 $1,759,955
Sale
Common Stock 1,202 $522.31 $627,815
Option
Non-Qualified Stock Option (right-to-buy) 6,680 $288.78 $1,929,050
Option
Common Stock 4,956 $206.94 $1,025,595
Sale
Common Stock 2,887 $511.22 $1,475,904
Option
Common Stock 5,865 $178.26 $1,045,495
Option
Common Stock 560 $178.26 $99,826
Option
Common Stock 7,151 $141.6 $1,012,582
Option
Common Stock 2,627 $68.75 $180,606
Sale
Common Stock 6,186 $510.38 $3,157,198
Option
Incentive Stock Option (right-to-buy) 1,266 $159.93 $202,471
Option
Non-Qualified Stock Option (right-to-buy) 15,643 $129.54 $2,026,347
Sale
Common Stock 500 $508.96 $254,482
Sale
Common Stock 2,545 $509.32 $1,296,222
Sale
Common Stock 7,473 $511.03 $3,818,920
Option
Common Stock 706 $141.6 $99,970
Sale
Common Stock 3,318 $510.47 $1,693,726
Option
Common Stock 216 N/A N/A
Option
Restricted Stock Unit 204 N/A N/A
Option
Restricted Stock Unit 161 N/A N/A
Option
Restricted Stock Unit 216 N/A N/A
Option
Restricted Stock Unit 127 N/A N/A
Option
Restricted Stock Unit 126 N/A N/A
Option
Common Stock 126 N/A N/A
Option
Common Stock 127 N/A N/A
Option
Common Stock 204 N/A N/A
Option
Common Stock 161 N/A N/A
Option
Restricted Stock Unit 150 N/A N/A
Option
Common Stock 126 N/A N/A
Option
Common Stock 127 N/A N/A
Option
Common Stock 217 N/A N/A
Option
Restricted Stock Unit 127 N/A N/A
Option
Common Stock 161 N/A N/A
Option
Restricted Stock Unit 126 N/A N/A
Option
Restricted Stock Unit 161 N/A N/A
Option
Common Stock 150 N/A N/A
Option
Restricted Stock Unit 217 N/A N/A
Sale
Common Stock 4,595 $633 $2,908,635
Sale
Common Stock 10,000 $562.27 $5,622,740
Option
Non-Qualified Stock Option (right-to-buy) 10,000 $67.85 $678,500
Sale
Common Stock 10,000 $562.27 $5,622,740
Option
Common Stock 10,000 $67.85 $678,500
Option
Common Stock 1,476 $67.85 $100,147
Option
Incentive Stock Option (right-to-buy) 1,476 $67.85 $100,147
Option
Restricted Stock Unit 863 N/A N/A
Option
Common Stock 863 N/A N/A
Option
Common Stock 863 N/A N/A
Option
Common Stock 16,264 $220.01 $3,578,308
Sale
Common Stock 1,126 $62 $69,812
Option
Non-Qualified Stock Option (right-to-buy) 1,126 $62 $69,812
Option
Incentive Stock Option (right-to-buy) 1,256 $79.54 $99,902
Option
Common Stock 1,256 $79.54 $99,902
Option
Restricted Stock Unit 853 N/A N/A
Option
Restricted Stock Unit 853 N/A N/A
Option
Common Stock 853 N/A N/A
Option
Restricted Stock Unit 1,318 N/A N/A
Option
Common Stock 1,318 N/A N/A
Option
Common Stock 5,459 $45.66 $249,258
Option
Incentive Stock Option (right to buy) 1,758 $45.66 $80,270
Option
Non-Qualified Stock Option (right to buy) 3,701 $45.66 $168,988
Sale
Common Stock 5,459 $95.01 $518,660
Option
Common Stock 1,847 N/A N/A
Option
Restricted Stock Unit 1,847 N/A N/A
Sale
Common Stock 17,236 $77.62 $1,337,841
Option
Incentive Stock Option (right to buy) 5,265 $56.95 $299,842
Option
Common Stock 18,868 $50.4 $950,853
Option
Non-Qualified Stock Option (right to buy) 13,603 $48.21 $655,801
Option
Common Stock 1,654 N/A N/A
Option
Restricted Stock Unit 1,654 N/A N/A
Option
Common Stock 1,374 N/A N/A
Option
Restricted Stock Unit 1,374 N/A N/A
Option
Common Stock 974 N/A N/A
Option
Restricted Stock Unit 974 N/A N/A
Option
Common Stock 716 N/A N/A
Option
Restricted Stock Unit 716 N/A N/A

IDEXX Laboratories key executives

IDEXX Laboratories, Inc. executives and other stock owners filed with the SEC: